IDO1 and carcinoma: In a study conducted by Uyttenhove et al. [15], immunohistochemical constitutive IDO-1 expression was observed in cases of prostatic, colorectal, pancreatic, cervical, and in nine of ten GBM carcinomas, in addition to several other tumor types.